Qing Xu | Obstetrics and Gynecology | Research Excellence Award

Published on by Invention Awards

Prof. Qing Xu | Obstetrics and Gynecology | Research Excellence Award

Professor at Women’s Hospital of Nanjing Medical University, China

Prof. Qing Xu is a Professor and Doctoral Supervisor at Women’s Hospital of Nanjing Medical University and Nanjing Women and Children’s Healthcare Hospital, with a PhD in Epidemiology and Health Statistics and extensive clinical and research experience in obstetrics and gynecology. Her research focuses on the etiology of female reproductive disorders, particularly miscarriage and adverse pregnancy outcomes associated with environmental exposures. She has led eight completed and ongoing national and provincial research projects integrating epidemiology, metabolomics, and clinical medicine. Over the past five years, her SCI-indexed publications have achieved a total impact factor exceeding 81.2, with more than 30 papers published in leading international journals such as Environment International and Journal of Hazardous Materials. She has authored two academic textbooks and monographs and holds one authorized Chinese invention patent. Prof. Xu serves as an Editorial Board Member of the Journal of Nanjing Medical University and maintains extensive multidisciplinary collaborations in environmental health and reproductive medicine. She is an active member of the International Society of Exposure Science and serves on standing committees and councils of several academic societies. Her work has elucidated the roles of metals, air pollution, and endocrine-disrupting chemicals in miscarriage and adverse pregnancy outcomes. By combining epidemiological methods with omics technologies, she has generated robust evidence for reproductive risk assessment. Her contributions support the development of effective prevention strategies to improve maternal and fetal health.

Citation Metrics (Scopus)

350
300
250
200
150
100
 50
 0

Citations
316

Documents
15

h-index
10

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Irene Deltetto | Women’s Health | Best Researcher Award

Published on by Invention Awards

Mrs. Irene Deltetto | Women’s Health | Best Researcher Award 

Mrs. Irene Deltetto | HTAnalysts | Australia

Mrs. Irene Deltetto is a healthcare strategist and public health professional with extensive experience in health economics, policy, and innovation. She holds a Master’s in Public Health from the University of Sydney, Australia, and a Master of Science in Economics and Management of Public Administrations and International Organisations, as well as a Bachelor in International Economics and Management from Università Commerciale Luigi Bocconi, Milan, Italy. She also completed Social Value and SROI training with Social Ventures Australia in 2019. Currently serving as the Director of Healthcare Strategy & Innovation at HTAnalysts, she leads initiatives in healthcare strategy, value creation, and impact evaluation while mentoring senior staff and promoting a values-driven culture. Her professional journey spans roles of increasing responsibility at HTAnalysts from Senior Consultant to Director where she has developed expertise in health economics, outcomes research, and social return on investment. Previously, she worked as a Life Sciences Consultant at Ernst & Young in Milan, contributing to EMA submissions, cost-utility models, and innovative therapy evaluations. Her earlier experience includes research and advocacy roles with the International Federation of Red Cross and Red Crescent Societies in Geneva, where she focused on maternal and child health. Irene’s therapeutic expertise covers women’s health, oncology, cardiovascular, rare diseases, and medical devices. She has been actively engaged with the Starlight Children’s Foundation as a board observer and volunteer, and has contributed to community health initiatives in Cameroon. An advocate for gender equity and women’s leadership in healthcare, she has presented at ISPOR International and other industry forums. Her academic and professional work has resulted in around 10 publications, over 200 citations, and an h-index of 8, reflecting her impactful contributions to healthcare value and innovation.

Profiles: Scopus | Orcid | Staff Page

Featured Publications

Deltetto, F., Deltetto, I., Giannantoni, A., Jorgensen, M., Landi, S., Manni, M., Marcato, L., Mirabella, D., Libretti, A., & Remorgida, V. (2025). Perioperative complications in the primary vaginal mesh surgery for pelvic organ prolapse. Surgeries, 6(4), 89.

Holcomb, M., De Raeve, L., Ramos Macías, Á., Jorgensen, M., Taylor, A. E., Deltetto, I., & Taylor, C. (2025). Hearing the call for change: Developing ‘living’ guidelines for the cochlear implantation process. The Hearing Journal, 78(7), 16–21.

Crowther, J., Hoek, A. C., Trieu, K., Denham, I., Deltetto, I., Balaguer-Mercado, A., Bullen, J. D., Kissock, K., Patay, D., & Rosewarne, E., et al. (2025). Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia: A qualitative study. BMC Public Health, 25, 3717.

Crowther, J., Bullen, J. D., Balaguer-Mercado, A., Wong Pan, R., Deltetto, I., Kissock, K., Hastings, B., Hoek, A. C., Webster, J., & Neal, B., et al. (2025). Increasing potassium-enriched salt use in Australia—Understanding the salt supply chain. Proceedings of the Nutrition Society, 84(2), 146–156.

Denham, I., Maurin, R., Deltetto, I., Mikolaizak, A. S., Waern, J. B., & Taylor, C. (2024). Levodopa-based device-aided therapies for the treatment of advanced Parkinson’s disease: A social return on investment analysis. Frontiers in Public Health, 12, 1351808.

Ramos-Macías, Á., De Raeve, L., Holcomb, M., Connor, E., Taylor, A., Deltetto, I., & Taylor, C. (2023). Strategies for the implementation of the living guidelines for cochlear implantation in adults. Frontiers in Public Health, 11, 1272437.

Maurin, R., Deltetto, I., Keay, L., Huang-Lung, J., & Taylor, C. (2023). Feasibility of providing collaborative glaucoma care from a community optometry perspective: A mixed-methods assessment. Clinical and Experimental Optometry, 106(2), 202–212.

Altaf, N., Ariyaratne, T. V., Peacock, A., Deltetto, I., El-Hoss, J., Thomas, S., Taylor, C., & Mwipatayi, B. P. (2021). A budget impact model for the use of drug-eluting stents in patients with symptomatic lower-limb peripheral arterial disease: An Australian perspective. CardioVascular and Interventional Radiology, 44(6), 914–923.